# A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients

> **NCT01234831** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 463 (actual)

## Conditions studied

- MRSA Colonization

## Interventions

- **DEVICE:** nucleic acid amplification of nasal swab; nasal swab culture
- **OTHER:** Nasal swab culture

## Key facts

- **NCT ID:** NCT01234831
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-09
- **Final completion:** 2016-03
- **Target enrollment:** 463 (ACTUAL)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01234831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01234831, "A Novel Approach to Methicillin-resistant Staphylococcus Aureus (MRSA) Screening of Colonized Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01234831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*